INIFY Laboratories AB Stock: price and insider trades · Norway

Every trade that managers of INIFY Laboratories AB disclose to Oslo Børs is tracked on this page. The company sits in the Health Care sector. Over the twelve months to 18 October 2026, the company's managers filed 6 filings, from 6 insiders.

No insider sold shares on the market over the period. Instead, the filings list 3 purchases totalling €34.4M, made by 3 insiders. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. At €34.4M, the purchase published on 27 August 2026 by Inify. For is the largest of the period.

In the case of 1 purchase, another manager of the company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. The most recent open-market purchase was published on 27 August 2026, 51 days ago.

Across the 257 companies tracked on its exchange, the median is 4 filings; at 6 filings, this issuer sits above that mark. The full history, which starts in 2022, counts 7 purchases against no sales.

In the same sector, recent insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. also feature in our signals. These figures are compiled from regulatory filings published by Oslo Børs. They describe what insiders did and are not a recommendation.